Literature DB >> 27168782

Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet β-cells in recent-onset type 1 diabetes in NOD mice.

Cheng Li1, Lijuan Zhang2, Yanyan Chen3, Xiaojie Lin2, Tang Li2.   

Abstract

The aim of the present study was to provide an animal experimental basis for the protective effect of the adenoviral vector-mediated interleukin-10 (Ad-mIL-10) gene on islet β-cells during the early stages of type 1 diabetes (T1D) in non-obese diabetic (NOD) mice. A total of 24 female NOD mice at the onset of diabetes were allocated at random into three groups (n=8 per group): Group 1, intraperitoneally injected with 0.1 ml Ad-mIL-10; group 2, intraperitoneally injected with 0.1 ml adenovirus vector; and group 3, was a diabetic control. In addition to groups 1, 2 and 3, 8 age- and gender-matched NOD mice were intraperitoneally injected with 0.1 ml PBS and assigned to group 4 as a normal control. All mice were examined weekly for body weight, urine glucose and blood glucose values prior to onset of diabetes, and at 1, 2 and 3 weeks after that, and all mice were sacrificed 3 weeks after injection. Serum levels of interleukin (IL)-10, interferon (IFN)-γ, IL-4, insulin and C-peptide were evaluated, and in addition the degree of insulitis and the local expression of IL-10 gene in the pancreas were detected. The apoptosis rate of pancreatic β-cells was determined using a TUNEL assay. Compared with groups 2 and 3, IL-10 levels in the serum and pancreas were elevated in group 1. Serum IFN-γ levels were decreased while serum IL-4 levels and IFN-γ/IL-4 ratio were significantly increased in group 1 (P<0.01). C-peptide and insulin levels were higher in group 1 compared with groups 2 and 3, (P<0.01). Furthermore, compared with groups 2 and 3, the degree of insulitis, islet β-cell apoptosis rate and blood glucose values did not change significantly (P>0.05). The administration of the Ad-mIL-10 gene induced limited immune regulatory and protective effects on islet β-cell function in NOD mice with early T1D, while no significant reduction in insulitis, islet β-cell apoptosis rate and blood glucose was observed.

Entities:  

Keywords:  immunotherapy; interleukin 10; non-obese diabetic mice; type 1 diabetes

Year:  2016        PMID: 27168782      PMCID: PMC4840566          DOI: 10.3892/etm.2016.3169

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  55 in total

1.  Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus.

Authors:  M A Berman; C I Sandborg; Z Wang; K L Imfeld; F Zaldivar; V Dadufalza; B A Buckingham
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

Review 2.  Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.

Authors:  Miriam Cnop; Nils Welsh; Jean-Christophe Jonas; Anne Jörns; Sigurd Lenzen; Decio L Eizirik
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

3.  Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.

Authors:  Hans Häcker; Vanessa Redecke; Blagoy Blagoev; Irina Kratchmarova; Li-Chung Hsu; Gang G Wang; Mark P Kamps; Eyal Raz; Hermann Wagner; Georg Häcker; Matthias Mann; Michael Karin
Journal:  Nature       Date:  2005-11-23       Impact factor: 49.962

4.  Haplotype associated with low interleukin-10 production in patients with severe asthma.

Authors:  S Lim; E Crawley; P Woo; P J Barnes
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

5.  Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development.

Authors:  Zuoxiang Xiao; Abdiaziz S Mohamood; Sophia Uddin; Rachel Gutfreund; Chiaki Nakata; Andrew Marshall; Hiroaki Kimura; Patrizio Caturegli; Karl L Womer; Yanfei Huang; Chunfa Jie; Shukti Chakravarti; Jonathan P Schneck; Hideo Yagita; Abdel Rahim A Hamad
Journal:  Am J Pathol       Date:  2011-06-15       Impact factor: 4.307

6.  Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine.

Authors:  Ai-Jing Xu; Wei Zhu; Fei Tian; Li-Hua Yan; Tang Li
Journal:  Mol Cell Biochem       Date:  2010-07-25       Impact factor: 3.396

Review 7.  IL-10 and TNFalpha genotypes in SLE.

Authors:  Patricia López; Carmen Gutiérrez; Ana Suárez
Journal:  J Biomed Biotechnol       Date:  2010-06-21

Review 8.  Mechanistic basis of immunotherapies for type 1 diabetes mellitus.

Authors:  Wenhao Chen; Aini Xie; Lawrence Chan
Journal:  Transl Res       Date:  2013-01-22       Impact factor: 7.012

9.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.

Authors:  M J Rapoport; A Jaramillo; D Zipris; A H Lazarus; D V Serreze; E H Leiter; P Cyopick; J S Danska; T L Delovitch
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Unique Features of Pancreatic-Resident Regulatory T Cells in Autoimmune Type 1 Diabetes.

Authors:  Jingli Lu; Chaoqi Zhang; Lifeng Li; Wenhua Xue; Chengliang Zhang; Xiaojian Zhang
Journal:  Front Immunol       Date:  2017-09-29       Impact factor: 7.561

2.  Type-I Interferons Inhibit Interleukin-10 Signaling and Favor Type 1 Diabetes Development in Nonobese Diabetic Mice.

Authors:  Marcos Iglesias; Anirudh Arun; Maria Chicco; Brandon Lam; C Conover Talbot; Vera Ivanova; W P A Lee; Gerald Brandacher; Giorgio Raimondi
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

3.  Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children.

Authors:  Aleksandra Starosz; Milena Jamiołkowska-Sztabkowska; Barbara Głowińska-Olszewska; Marcin Moniuszko; Artur Bossowski; Kamil Grubczak
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

4.  Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells.

Authors:  Yinxing Shen; Junqi Zhang; Weiju Hao; Tong Wang; Jing Liu; Youhua Xie; Shouhong Xu; Honglai Liu
Journal:  Int J Nanomedicine       Date:  2018-01-25

Review 5.  Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes.

Authors:  Charles J Kroger; Matthew Clark; Qi Ke; Roland M Tisch
Journal:  Front Immunol       Date:  2018-08-16       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.